Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24453,997,1.23 [1.02-1.48],0.0298629009782093
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24362,196,2.25 [1.50-3.37],8.412478855920594e-05
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26400,192,1.18 [0.78-1.77],0.4419631773927267
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18631,773,1.31 [1.06-1.62],0.0121474299766586
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26333,125,1.55 [0.94-2.58],0.0886201240449981
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25253,83,1.90 [1.02-3.54],0.0442539070783354
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27787,124,1.56 [0.94-2.59],0.0845435851873295
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27781,84,1.23 [0.66-2.27],0.5121878490892371
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24616,65,3.33 [1.66-6.67],0.0006751632353093
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27106,121,2.37 [1.43-3.93],0.000831123608691
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27055,70,2.18 [1.12-4.25],0.0216296440185535
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27867,79,1.24 [0.65-2.35],0.5168752312477958
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27833,101,1.35 [0.77-2.36],0.3013973926467387
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27828,96,1.33 [0.75-2.38],0.3299592309361254
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,27482,63,0.87 [0.42-1.77],0.6921457223517056
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26663,442,1.30 [0.99-1.70],0.0619989229605454
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26353,132,2.16 [1.32-3.52],0.0021237986504688
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26527,306,0.98 [0.71-1.36],0.9075949984189466
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22805,52,0.89 [0.40-1.96],0.7689664558295075
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22816,63,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23012,259,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23020,267,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23433,680,0.86 [0.69-1.08],0.1960518178574598
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22806,53,1.01 [0.46-2.23],0.974405695292934
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24984,1035,1.09 [0.91-1.30],0.3685715181077851
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26778,296,0.84 [0.60-1.17],0.3012714741912423
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27520,110,0.81 [0.47-1.39],0.4455612946678274
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27963,91,0.71 [0.39-1.29],0.2666302839375882
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,27745,59,0.70 [0.34-1.47],0.3507784584922492
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27964,70,1.44 [0.73-2.82],0.2938793136335886
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Stomach,28011,55,1.35 [0.63-2.90],0.436706128034655
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,27784,278,1.06 [0.75-1.49],0.754609380108644
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27959,111,0.95 [0.55-1.63],0.8439167982004188
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27958,107,1.53 [0.89-2.63],0.1270647223639126
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27892,69,0.77 [0.39-1.54],0.4653395330561252
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",27894,68,0.79 [0.39-1.57],0.4933362912789172
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,27793,267,1.15 [0.81-1.64],0.4380313100448395
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27969,121,1.15 [0.68-1.94],0.6061108963930317
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,27858,228,0.80 [0.55-1.16],0.2378854184468737
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of breast,27949,138,1.45 [0.89-2.36],0.1321142393657824
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,27432,1014,0.85 [0.71-1.02],0.0720545672164758
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26581,272,1.00 [0.71-1.42],0.980742523905788
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26312,450,1.00 [0.76-1.31],0.9982875504769614
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26312,450,1.00 [0.76-1.31],0.9982875504769614
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24753,421,1.33 [1.01-1.77],0.0445520065505652
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27432,98,1.61 [0.91-2.86],0.1052339399785478
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27655,108,1.51 [0.87-2.60],0.1426441649283009
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23221,927,0.99 [0.81-1.20],0.880514994872603
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,25646,915,1.06 [0.87-1.28],0.5565988133702641
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26132,122,9.31 [5.77-15.02],6.186642415342632e-20
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26992,61,1.29 [0.63-2.64],0.4892316109802065
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26120,110,8.59 [5.19-14.23],6.612421133794195e-17
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26426,416,1.40 [1.06-1.86],0.0185491015356312
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26417,407,1.39 [1.04-1.85],0.0248721280234653
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25892,199,0.83 [0.55-1.27],0.3937079723695322
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25895,196,0.85 [0.55-1.29],0.4402204832773038
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23026,732,0.90 [0.72-1.12],0.3515013689857568
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22377,83,0.98 [0.52-1.83],0.9519106267141824
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22973,679,0.94 [0.75-1.17],0.5728799110085978
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22345,51,2.44 [1.11-5.35],0.0258684978763694
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",22366,72,1.50 [0.77-2.95],0.2353687107218692
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,23630,625,0.79 [0.63-1.00],0.0470406574852588
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23124,119,0.52 [0.31-0.88],0.0145752906071718
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27768,79,0.32 [0.17-0.60],0.0003703503407743
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27809,47,0.30 [0.13-0.66],0.0029472346520571
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26546,38,0.35 [0.14-0.85],0.0212935704743664
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27962,38,0.37 [0.15-0.90],0.0281740313490885
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23043,38,0.34 [0.14-0.83],0.0177667182468146
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Alcohol dependence,26532,24,0.75 [0.24-2.32],0.617292499504049
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,26424,36,1.51 [0.60-3.79],0.383575826391235
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23049,44,0.83 [0.36-1.94],0.6677867785711243
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23389,384,0.85 [0.64-1.14],0.2866392415056424
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression,25981,341,0.76 [0.56-1.04],0.085863181711047
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression or dysthymia,23171,300,0.75 [0.54-1.05],0.0936795556629981
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23155,150,0.76 [0.48-1.21],0.2453529250789936
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Other anxiety disorders,26066,76,0.72 [0.38-1.38],0.3257455567561357
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,24145,1651,0.91 [0.79-1.06],0.2307096205579353
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22083,183,0.30 [0.20-0.47],5.2087273396020004e-08
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27812,154,0.29 [0.19-0.46],1.253433594564918e-07
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26647,428,0.97 [0.74-1.28],0.8326536145676471
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,26359,140,0.95 [0.59-1.54],0.8339972583797572
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,26347,128,1.12 [0.68-1.87],0.6525283955336869
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27558,119,1.13 [0.67-1.91],0.6487563908167191
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27300,59,1.20 [0.58-2.50],0.62323113079794
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,26317,98,0.72 [0.41-1.27],0.2589551074634506
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,27585,69,1.15 [0.59-2.27],0.6788096941117587
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26611,867,1.12 [0.92-1.36],0.2533712749116669
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25867,123,1.61 [0.97-2.69],0.0662234987051807
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26301,557,1.11 [0.87-1.42],0.3960791738898068
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27746,76,0.36 [0.19-0.68],0.0017904222045535
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,27726,56,0.38 [0.18-0.80],0.010828849351744
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,27514,126,0.88 [0.53-1.46],0.6202059873798902
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27260,432,0.97 [0.74-1.28],0.8543264851829052
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27081,253,1.00 [0.70-1.42],0.9796891095226846
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26900,72,0.83 [0.42-1.63],0.5857339965230824
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26963,135,1.03 [0.63-1.69],0.8939898126171063
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26936,108,1.16 [0.67-2.00],0.6037878308615537
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23799,183,1.13 [0.74-1.71],0.5801711650258907
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24038,422,1.03 [0.78-1.37],0.810416921391429
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26950,188,1.64 [1.09-2.48],0.0183405617040758
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27738,35,,
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1806,35,,
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25967,35,,
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27298,96,1.18 [0.66-2.11],0.5713008663089776
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27256,54,0.89 [0.41-1.93],0.7647092435068106
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27151,97,0.79 [0.44-1.42],0.4327112724548998
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27424,102,0.96 [0.55-1.69],0.8983133429096757
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27881,132,0.88 [0.54-1.44],0.6169944056608524
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27198,103,1.05 [0.60-1.83],0.8668130830316523
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20626,2843,0.94 [0.82-1.06],0.2954833655349046
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27423,77,0.74 [0.39-1.41],0.3649659805187712
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21657,2091,0.89 [0.78-1.03],0.1209985597285591
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,21679,2113,0.93 [0.81-1.07],0.3372148658200321
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19617,51,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26303,740,1.12 [0.90-1.38],0.3104308211303457
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,26077,514,1.09 [0.84-1.40],0.5233914463715672
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27331,154,1.44 [0.92-2.26],0.1140289595063668
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27410,233,1.22 [0.84-1.76],0.2990954779478338
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27941,28,1.03 [0.36-2.95],0.9598187179105512
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25660,97,0.79 [0.44-1.42],0.4347110313982055
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26038,487,1.23 [0.95-1.60],0.1134019633553443
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27211,99,1.85 [1.06-3.25],0.0318298080548868
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27314,219,1.14 [0.78-1.68],0.497186665515946
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27210,98,1.26 [0.71-2.23],0.4283040453578558
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27210,98,1.26 [0.71-2.23],0.4283040453578558
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19661,95,1.17 [0.64-2.14],0.6008962420611632
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24325,39,1.65 [0.66-4.09],0.2825566335369125
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,24366,80,0.86 [0.45-1.63],0.6347310186586588
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16826,105,1.21 [0.68-2.15],0.5215198225169808
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17002,281,1.66 [1.16-2.38],0.0058005652726113
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,24338,52,0.88 [0.40-1.93],0.7456969529857413
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24345,59,1.67 [0.79-3.49],0.1766367862103788
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27150,103,1.82 [1.05-3.15],0.0336026247969519
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27212,127,0.82 [0.50-1.36],0.4386248874068424
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27254,96,0.92 [0.52-1.64],0.7768413753130119
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27325,84,0.87 [0.47-1.61],0.6528815812267886
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27016,71,1.34 [0.68-2.63],0.3947218314520622
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27060,115,1.30 [0.77-2.20],0.3301910943903573
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26363,133,0.83 [0.51-1.36],0.4608093258857448
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26336,106,1.25 [0.72-2.16],0.4300411693205082
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27796,103,1.19 [0.68-2.08],0.5336892894706582
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,26846,616,0.91 [0.72-1.15],0.4352234683433839
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,26852,93,0.77 [0.43-1.39],0.3924466837975064
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22757,2138,0.86 [0.76-0.98],0.0261155787023682
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27793,129,0.93 [0.57-1.54],0.782672107442942
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26330,203,1.22 [0.82-1.83],0.3288485905871564
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26311,184,1.19 [0.78-1.81],0.4264220011942703
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27085,232,0.51 [0.35-0.74],0.0003731364581469
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27077,224,0.51 [0.35-0.75],0.0005199519474138
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27231,572,0.95 [0.75-1.21],0.6906343521142418
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,26774,115,0.72 [0.42-1.23],0.2292197205047319
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,26740,81,0.92 [0.49-1.73],0.7841658213037869
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27018,359,0.89 [0.66-1.21],0.4631248462765933
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,26802,143,0.87 [0.54-1.40],0.5655015287404024
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13490,65,0.88 [0.43-1.80],0.7234012281591551
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25004,1185,0.86 [0.73-1.02],0.089697280413386
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,26929,161,0.76 [0.48-1.18],0.2198725036513742
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26949,181,0.94 [0.61-1.44],0.7730012255625021
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26949,181,0.94 [0.61-1.44],0.7730012255625021
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25919,1018,0.81 [0.68-0.97],0.0244506226266095
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Asthma,20797,1018,0.78 [0.64-0.93],0.0075604470208244
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20603,1018,0.78 [0.64-0.93],0.0075901632129635
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20782,1003,0.78 [0.65-0.94],0.0102478367556251
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27678,85,1.47 [0.80-2.71],0.2122462468260864
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,26187,64,1.45 [0.72-2.94],0.3013822703479244
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27755,64,1.44 [0.71-2.90],0.3094015041316954
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26180,57,1.07 [0.51-2.26],0.8624081538682504
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,26132,89,0.77 [0.42-1.41],0.3928956145959219
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,26238,195,0.88 [0.58-1.32],0.5362181510471934
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,26823,93,0.97 [0.54-1.74],0.9180455543051916
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19376,6102,0.85 [0.78-0.93],0.0004747017753642
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27431,481,1.03 [0.79-1.33],0.8513492878763511
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27965,108,1.14 [0.65-1.98],0.6531282132367184
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,27970,97,1.08 [0.60-1.95],0.786850404821053
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,27058,108,0.98 [0.57-1.68],0.9315540067326368
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27069,119,0.82 [0.49-1.38],0.4544427995723227
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27955,119,1.13 [0.66-1.91],0.6565588195021068
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27067,117,0.76 [0.45-1.29],0.3163310509131501
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26761,79,0.77 [0.40-1.45],0.4132247673823073
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27869,49,0.84 [0.37-1.88],0.6720903013766177
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21164,224,0.74 [0.51-1.09],0.1237586448342089
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23288,2348,0.96 [0.85-1.09],0.5476542227570209
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,21229,289,0.83 [0.59-1.17],0.286136479350825
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21689,749,0.94 [0.76-1.16],0.5533696910604015
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21020,80,1.10 [0.58-2.07],0.7780285339817026
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21075,135,0.93 [0.57-1.53],0.7851657917231141
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20980,40,0.88 [0.36-2.17],0.7877604647903357
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,21088,148,0.61 [0.38-0.98],0.0397949583959532
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,21017,77,0.78 [0.41-1.50],0.4564687351463993
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27918,55,0.79 [0.37-1.70],0.5477837473364762
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,21076,136,0.98 [0.60-1.60],0.9345735778345976
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21795,855,1.06 [0.87-1.30],0.5424965396005239
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,27841,147,0.80 [0.50-1.28],0.3426509262720149
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,21525,585,1.18 [0.93-1.50],0.1688939876563986
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21124,184,1.10 [0.72-1.68],0.647670750459313
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27879,143,1.15 [0.72-1.86],0.5578863015000323
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,27813,119,1.01 [0.60-1.71],0.959049907429336
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,25062,1216,0.73 [0.62-0.87],0.0003439006002658
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,23915,69,0.54 [0.27-1.07],0.0795733438623317
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,23919,73,0.57 [0.30-1.09],0.0867179911732465
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,23955,109,0.80 [0.46-1.37],0.416072602998369
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24816,970,0.75 [0.62-0.91],0.0028559639953813
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26896,925,1.13 [0.93-1.36],0.220879884165222
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,22172,2222,0.89 [0.78-1.01],0.075178603635481
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27649,64,0.85 [0.41-1.74],0.6553903532961504
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27935,93,1.06 [0.58-1.91],0.8534114607846822
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,26064,93,1.06 [0.58-1.92],0.8564926555955883
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26039,68,1.02 [0.51-2.05],0.9501673873498696
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",27856,136,2.17 [1.34-3.51],0.001694184754676
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,26107,136,2.17 [1.34-3.53],0.0017179185065237
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26093,122,2.45 [1.47-4.07],0.0005891560053192
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26753,782,1.06 [0.86-1.30],0.5794255140826438
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26742,771,1.06 [0.86-1.30],0.6107238746700234
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20060,110,1.07 [0.62-1.86],0.8019374980098404
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal stricture,27526,110,1.10 [0.64-1.90],0.7267084031109659
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20019,69,1.08 [0.54-2.17],0.823986147675632
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20631,681,0.73 [0.59-0.92],0.0070723207999191
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20198,248,0.73 [0.50-1.05],0.0881103637019695
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,20348,398,1.03 [0.77-1.38],0.8267161283703242
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,26273,354,1.18 [0.87-1.60],0.2830915065264976
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27479,130,1.04 [0.63-1.72],0.8655023534712465
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20076,126,1.23 [0.74-2.05],0.4275382994374013
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19996,46,1.55 [0.68-3.57],0.2989922814203214
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20852,902,0.92 [0.76-1.12],0.4252521606893296
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,20185,235,0.75 [0.52-1.09],0.1259006422153365
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27461,112,0.95 [0.56-1.63],0.8578359676917012
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,27202,108,1.78 [1.04-3.06],0.0364044278201105
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,27150,56,0.91 [0.43-1.95],0.814232560743426
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26409,895,0.90 [0.75-1.10],0.3100124756407365
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,26263,749,0.87 [0.71-1.08],0.2024266989344856
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,25647,133,0.79 [0.48-1.29],0.3419422588673509
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25585,71,2.09 [1.07-4.07],0.030649643350204
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,25577,63,1.49 [0.74-3.02],0.2671021943991873
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),27847,63,1.50 [0.74-3.04],0.261740347562199
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26594,315,1.02 [0.74-1.41],0.8969607837171149
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26385,106,nan [nan-nan],
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,26369,90,1.70 [0.93-3.10],0.0854248183100206
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26320,41,0.70 [0.29-1.71],0.4356989861504924
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26452,173,0.73 [0.48-1.13],0.1599763812037549
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,26442,163,0.74 [0.47-1.16],0.1867802290790879
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,24783,1642,1.00 [0.86-1.15],0.9695248281629176
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27536,116,0.83 [0.49-1.41],0.4942395547748549
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27537,461,0.93 [0.71-1.22],0.6067648151026399
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26395,710,1.06 [0.85-1.31],0.6124358735381448
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27167,326,1.09 [0.79-1.49],0.6035265170591159
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26910,69,1.08 [0.54-2.14],0.8286826168615542
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27051,210,1.24 [0.84-1.84],0.2728057751138475
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27715,91,1.11 [0.61-2.00],0.7357366044374294
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27689,65,0.96 [0.48-1.93],0.9086937780620508
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27675,51,1.22 [0.56-2.69],0.6143513797724706
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27730,56,0.74 [0.34-1.58],0.4307715199477528
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27727,53,0.69 [0.32-1.51],0.3517835934453704
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27131,55,0.81 [0.38-1.73],0.579461039170952
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27440,364,1.02 [0.76-1.38],0.8880254113672759
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25789,104,0.56 [0.32-0.98],0.043243424201745
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25844,159,1.18 [0.75-1.86],0.4722711959669659
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25800,115,0.85 [0.49-1.44],0.5379984920355702
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25945,260,1.21 [0.85-1.73],0.2914840836883304
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25920,235,1.45 [1.00-2.10],0.0525763401819139
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19730,4473,1.00 [0.90-1.10],0.9544422828135488
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21495,2573,0.95 [0.84-1.08],0.4536238622267758
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25134,1351,1.09 [0.93-1.27],0.3070472613260447
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19133,211,0.96 [0.64-1.42],0.8261317618565586
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19445,523,1.01 [0.78-1.30],0.9616910911212336
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27412,202,0.98 [0.66-1.46],0.9247297477355988
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27429,184,0.97 [0.64-1.48],0.8970605063512439
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20173,1251,0.87 [0.74-1.04],0.1277133059471041
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22922,1251,0.88 [0.75-1.05],0.1520445415096207
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18934,12,2.63 [0.58-11.83],0.2087850771939758
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27799,12,3.18 [0.69-14.71],0.1394270683460323
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19205,283,0.96 [0.68-1.34],0.7947789519575267
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19010,88,0.81 [0.44-1.48],0.4873671358188771
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19234,312,0.57 [0.41-0.79],0.0007752355984126
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27802,157,0.63 [0.40-1.00],0.0480798456815143
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19414,492,0.81 [0.62-1.05],0.1089513538664424
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19416,494,1.22 [0.94-1.59],0.1345775383151533
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20362,1440,1.05 [0.90-1.23],0.5331020592539581
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19030,108,1.07 [0.62-1.87],0.8035014012043867
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19351,429,0.87 [0.65-1.15],0.3197909534452309
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19006,84,1.14 [0.61-2.13],0.6914686211402544
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19029,107,0.58 [0.33-1.01],0.0522995292729519
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19298,376,1.23 [0.91-1.65],0.1781884943231982
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19242,320,1.16 [0.84-1.60],0.3681828139576586
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20873,303,0.90 [0.65-1.25],0.5263439933569829
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27162,221,2.51 [1.72-3.66],1.7082365083476635e-06
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27036,95,2.75 [1.55-4.87],0.0005466338821872
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23969,83,0.49 [0.26-0.90],0.0223728498077033
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24195,309,1.15 [0.83-1.59],0.405366828732088
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24930,1044,0.93 [0.78-1.11],0.4225878810677629
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24103,217,0.98 [0.67-1.44],0.9223167264806827
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23965,79,1.29 [0.69-2.43],0.4295524507693031
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",24716,830,0.95 [0.78-1.17],0.644671292948326
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23939,53,1.01 [0.46-2.21],0.9730811730852568
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24131,245,1.11 [0.77-1.60],0.5777161544465261
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23990,104,1.53 [0.88-2.68],0.1329695236012382
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23978,92,0.62 [0.35-1.13],0.1180851247933256
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24051,165,0.83 [0.54-1.30],0.4213365405418534
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23961,75,0.59 [0.31-1.14],0.1144943830604096
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24242,356,1.01 [0.74-1.36],0.9742067015386268
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24173,390,1.00 [0.74-1.33],0.97584031772974
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23857,74,0.68 [0.35-1.33],0.2602370847452609
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23895,112,1.39 [0.81-2.38],0.2261810187118247
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23927,144,0.95 [0.59-1.53],0.8366197503409182
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23822,39,0.79 [0.32-1.97],0.6093422153777268
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23842,59,0.67 [0.32-1.42],0.3014557269099576
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23826,43,0.73 [0.30-1.74],0.4719871493487811
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24067,284,1.12 [0.80-1.57],0.5217467638018294
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23844,61,1.00 [0.48-2.06],0.9918603158776244
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23853,70,0.75 [0.38-1.47],0.4030886522623738
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23925,142,0.97 [0.60-1.56],0.8934962509347826
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23865,82,1.26 [0.67-2.38],0.4699106313780005
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24326,543,1.07 [0.84-1.37],0.5836887365315239
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23977,194,0.90 [0.60-1.36],0.6268774155717849
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24074,291,1.13 [0.81-1.58],0.4597562485187808
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25211,241,1.18 [0.82-1.71],0.3729820444206762
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,25461,491,1.15 [0.89-1.49],0.296816893306924
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25010,40,1.24 [0.50-3.05],0.6429575227045381
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25036,66,0.91 [0.45-1.84],0.7858479202954006
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25086,116,0.99 [0.58-1.69],0.9805088233668704
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22853,6215,0.95 [0.87-1.04],0.2477128407172631
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,25499,202,7.93 [5.40-11.65],4.5231821372046055e-26
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25342,45,4.47 [1.96-10.24],0.0003871321018562
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,25674,37,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,25682,45,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25680,43,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27756,136,1.23 [0.75-1.99],0.4131415672006465
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27634,68,2.41 [1.23-4.72],0.0103999596369315
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27723,103,1.20 [0.68-2.09],0.5312654720072599
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27658,38,1.54 [0.61-3.85],0.357826206324362
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25739,1277,0.98 [0.84-1.16],0.8514443682881085
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,24600,138,1.62 [1.00-2.64],0.0509797797653487
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24550,88,0.85 [0.46-1.56],0.5965740126058902
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24634,172,0.92 [0.60-1.43],0.7183965181405843
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24553,91,0.94 [0.52-1.70],0.834647775530088
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25467,1005,0.98 [0.81-1.18],0.8265234890460935
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27686,483,0.91 [0.70-1.19],0.4991458586290612
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27352,149,0.99 [0.62-1.57],0.9501791188689565
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27373,170,0.91 [0.59-1.41],0.6811496130128684
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27317,114,1.07 [0.63-1.82],0.8095104438171064
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27622,567,1.01 [0.80-1.29],0.9172678277318348
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27189,134,1.10 [0.67-1.80],0.7062144775341217
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27309,254,0.92 [0.64-1.32],0.6641603834306219
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25525,4650,0.82 [0.75-0.90],3.539155713432932e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,21242,367,0.60 [0.45-0.82],0.0011179342507968
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20972,97,1.00 [0.56-1.79],0.996170992945378
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21045,170,0.42 [0.27-0.65],8.784977186990524e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21681,806,0.67 [0.54-0.82],0.0001121597361625
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21290,415,0.75 [0.56-0.99],0.0440453244164632
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21847,972,0.78 [0.64-0.94],0.0087117321497055
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21197,322,0.80 [0.58-1.10],0.1717540051357946
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21322,447,0.74 [0.57-0.98],0.0328377444901764
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20977,102,0.85 [0.48-1.51],0.58554093282317
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21065,190,1.30 [0.86-1.97],0.2180348060853635
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27964,269,1.37 [0.96-1.94],0.0797060722985724
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27976,255,1.33 [0.93-1.90],0.1240095270827564
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28002,142,1.62 [1.00-2.61],0.050301752135915
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27991,156,1.55 [0.98-2.44],0.0625206274883428
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21024,149,0.77 [0.48-1.23],0.2692589000158409
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20991,116,0.84 [0.49-1.43],0.5143147490034274
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21021,146,0.82 [0.51-1.32],0.4165648610711248
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,27894,471,0.83 [0.63-1.08],0.157276307839822
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22232,1357,0.72 [0.61-0.85],7.305908295740225e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21759,884,0.66 [0.54-0.81],4.817717338238815e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27981,197,1.08 [0.72-1.62],0.7165028684766346
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21348,473,0.81 [0.62-1.06],0.1247442716349423
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21206,331,0.88 [0.64-1.20],0.416578316157803
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21780,905,0.84 [0.69-1.02],0.0750968926683979
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female infertility,20992,117,1.01 [0.59-1.75],0.9628791358917544
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20985,110,1.02 [0.58-1.79],0.9394872998407868
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27998,890,0.84 [0.68-1.05],0.123412436840663
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28004,1214,0.74 [0.61-0.89],0.0020365665159618
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27999,484,0.63 [0.48-0.83],0.0008980028997768
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27653,138,0.64 [0.39-1.07],0.0897256044081848
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27708,193,0.63 [0.41-0.97],0.0379199756353557
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27682,167,0.50 [0.32-0.79],0.0027455497939979
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28018,167,0.96 [0.61-1.51],0.8507936784093382
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28020,164,0.99 [0.62-1.56],0.9491630501219048
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28015,424,0.69 [0.51-0.92],0.0126358859169162
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27718,127,0.87 [0.52-1.46],0.5975245333643738
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27825,234,0.67 [0.45-1.00],0.0473308313004378
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27258,150,0.49 [0.30-0.81],0.005310268901135
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27311,203,0.85 [0.56-1.30],0.4508822669704894
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27363,255,0.82 [0.56-1.19],0.2950612751810516
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27259,151,0.89 [0.55-1.46],0.6552855829630335
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27247,139,0.83 [0.50-1.38],0.4796898016204648
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27261,153,0.60 [0.37-0.97],0.0380712459241099
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27024,234,0.79 [0.53-1.17],0.2368141272506814
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27231,441,0.78 [0.58-1.04],0.0933516733655254
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27470,680,0.74 [0.57-0.95],0.0167324740865725
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28020,173,0.63 [0.40-1.00],0.0476244951659325
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26544,132,0.66 [0.39-1.11],0.1161973448200176
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26895,105,0.78 [0.44-1.41],0.4202676235722495
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28028,349,0.78 [0.56-1.07],0.1269459095975401
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27945,266,0.76 [0.52-1.10],0.1427624918941458
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28016,257,0.89 [0.61-1.30],0.5420843187764177
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28006,247,0.87 [0.59-1.27],0.4713077154522592
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27720,45,0.77 [0.33-1.76],0.5307397260227295
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,25067,653,0.84 [0.67-1.06],0.1433809046420928
